CoreCap Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

CoreCap Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$933	Hold	235	–	–	﹤0.01%	2674
2026 Q2	$989	Hold	235	–	–	﹤0.01%	2696
2026 Q1	$825	Hold	235	–	–	﹤0.01%	2561
2025 Q4	$792	Hold	235	–	–	﹤0.01%	2636
2025 Q3	$308	Buy	+235	New	+$243	﹤0.01%	2623
2025 Q2	–	Sell	-175	Closed	-$257	–	3002
2025 Q1	$257	Buy	+175	New	+$417	﹤0.01%	2863

Other funds holding IRWD

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Range Financial Group Tigard, Oregon $361M AUM 58.71% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

CoreCap Advisors's IRWD Position: Q3 2026 in Review

CoreCap Advisors held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2026 at 235 shares worth $933. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

CoreCap Advisors first reported a position in IRWD in Q1 2025 and has held it in 6 quarters since. The position peaked at $989 in Q2 2026. 22 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

CoreCap Advisors held 235 shares of Ironwood Pharmaceuticals worth $933 as of Q3 2026.
CoreCap Advisors left its Ironwood Pharmaceuticals share count unchanged in Q3 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2674 holding.
CoreCap Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
CoreCap Advisors's Ironwood Pharmaceuticals position peaked at $989 in Q2 2026.
22 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.